1309980-29-7 Usage
Uses
Used in Organic Synthesis:
2-Methyl-4-trifluoroMethoxyphenylboronic acid, pinacol ester is used as a reagent in organic synthesis for its ability to facilitate the formation of carbon-carbon and carbon-heteroatom bonds. Its versatility in forming these bonds is crucial for the creation of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 2-Methyl-4-trifluoroMethoxyphenylboronic acid, pinacol ester is used as a key intermediate in the synthesis of various drugs. Its role in creating specific molecular structures is essential for the development of new medications with unique therapeutic properties.
Used in Agrochemical Production:
Similarly, in the agrochemical sector, 2-Methyl-4-trifluoroMethoxyphenylboronic acid, pinacol ester is utilized as a building block for the synthesis of pesticides and other crop protection agents. Its contribution to the formation of active ingredients is vital for enhancing agricultural productivity and crop protection.
Used in Material Science:
2-Methyl-4-trifluoroMethoxyphenylboronic acid, pinacol ester is also employed in material science for the development of new materials with specific properties. Its role in creating novel molecular structures contributes to the advancement of material technologies in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1309980-29-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,9,9,8 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1309980-29:
(9*1)+(8*3)+(7*0)+(6*9)+(5*9)+(4*8)+(3*0)+(2*2)+(1*9)=177
177 % 10 = 7
So 1309980-29-7 is a valid CAS Registry Number.
1309980-29-7Relevant articles and documents
COMPOUNDS AND THEIR METHODS OF USE
-
, (2020/12/13)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
COMPOUNDS AND THEIR METHODS OF USE
-
, (2018/06/12)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
Investigation of (E)-3-[4-(2-oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic acids as oral selective estrogen receptor down-regulators
Degorce, Sébastien L.,Bailey, Andrew,Callis, Rowena,De Savi, Chris,Ducray, Richard,Lamont, Gillian,MacFaul, Philip,Maudet, Mickael,Martin, Scott,Morgentin, Rémy,Norman, Richard A.,Peru, Aurélien,Pink, Jennifer H.,Plé, Patrick A.,Roberts, Bryan,Scott, James S.
supporting information, p. 3522 - 3533 (2015/05/05)
A novel estrogen receptor down-regulator, 7-hydroxycoumarin (5, SS5020), has been reported with antitumor effects against chemically induced mammary tumors. Here, we report on our own investigation of 7-hydroxycoumarins as potential selective estrogen rec